Plain-English translation of NCT06736002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether vitamin D supplements can help people with epilepsy — especially those whose seizures don't respond well to standard medications. You would receive a high initial dose of vitamin D followed by regular maintenance doses over time. Researchers will track how often your seizures occur, how tired you feel, and how your overall quality of life changes.
Some patients with epilepsy continue having seizures even after trying multiple medications, and doctors are looking for additional tools to help manage this condition. This trial explores whether this medication might work alongside standard epilepsy treatments to reduce seizure frequency and improve how patients feel day-to-day.
You likely qualify if…
You likely don't qualify if…
You would receive vitamin D supplements in a special two-step approach: a high initial dose followed by regular maintenance doses. Throughout the study, the research team will collect information about how often your seizures happen, your energy levels, and your quality of life. You or your caregiver will need to be able to commit to the study plan and attend visits as scheduled.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Taiwan
Sponsor
Chin-Wei Huang
Enrollment target
~200 participants
Started
February 2025
Primary completion
December 2026
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shiue Yu Chen, Master
National Cheng-Kung University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.